UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 120

Sortiert nach

Antiphospholipid syndrome: antibodies to Domain 1 of β2‐glycoprotein 1 correctly classify patients at risk

Journal of thrombosis and haemostasis, 2015-05, Vol.13 (5), p.782-787

2015

Volltextzugriff (PDF)

ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study

International journal of cardiology, 2024-01, Vol.394, p.131369-131369, Article 131369

2024

Volltextzugriff (PDF)

The role of platelets in antiphospholipid syndrome

Platelets (Edinburgh), 2017-11, Vol.28 (8), p.762-766

2017

Volltextzugriff (PDF)

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

Journal of thrombosis and haemostasis, 2010-02, Vol.8 (2), p.237-242

2010

Volltextzugriff (PDF)

Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial

Lupus, 2016-03, Vol.25 (3), p.301-306

2016

Volltextzugriff (PDF)

Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns

Thrombosis research, 2018-12, Vol.172, p.172-178

2018

Volltextzugriff (PDF)

Thrombocytopenia in high‐risk patients with antiphospholipid syndrome

Journal of thrombosis and haemostasis, 2018-03, Vol.16 (3), p.529-532

2018

Volltextzugriff (PDF)

Low platelet count at admission has an adverse impact on outcome in patients with acute coronary syndromes: from the START Antiplatelet registry

Scientific reports, 2024-06, Vol.14 (1), p.14516-10, Article 14516

2024

Volltextzugriff (PDF)

Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile

Journal of thrombosis and haemostasis, 2013-08, Vol.11 (8), p.1527-1531

2013

Volltextzugriff (PDF)

Standardized Low―Molecular-Weight Heparin Bridging Regimen in Outpatients on Oral Anticoagulants Undergoing Invasive Procedure or Surgery: An Inception Cohort Management Study

Circulation (New York, N.Y.), 2009-06, Vol.119 (22), p.2920-2927

2009

Volltextzugriff (PDF)

An in vitro model to mimic the thrombotic occlusion of small vessels in catastrophic antiphospholipid syndrome (CAPS)

Lupus, 2019-12, Vol.28 (14), p.1663-1668

2019

Volltextzugriff (PDF)

Correct laboratory approach to APS diagnosis and monitoring

Autoimmunity reviews, 2013-06, Vol.12 (8), p.832-834

2013

Volltextzugriff (PDF)

Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs)

Thrombosis research, 2018-03, Vol.163, p.100-104

2018

Volltextzugriff (PDF)

APS - Diagnostics and challenges for the future

Autoimmunity reviews, 2016-11, Vol.15 (11), p.1031-1033

2016

Volltextzugriff (PDF)

Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles

Thrombosis research, 2015-07, Vol.136 (1), p.161-163

2015

Volltextzugriff (PDF)

Antibodies to Domain I of β(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

Thrombosis research, 2011-12, Vol.128 (6), p.583-586

2011

Volltextzugriff (PDF)

Laboratory testing for antiphospholipid syndrome

International journal of laboratory hematology, 2016-05, Vol.38 (S1), p.27-31

2016

Volltextzugriff (PDF)

Interpretation of laboratory data and need for reference laboratories

Lupus, 2012-06, Vol.21 (7), p.732-733

2012

Volltextzugriff (PDF)

Antiphospholipid syndrome: critical analysis of the diagnostic path

Lupus, 2010-04, Vol.19 (4), p.428-431

2010

Volltextzugriff (PDF)

Secondary prevention in thrombotic antiphospholipid syndrome

Lupus, 2012-06, Vol.21 (7), p.734-735

2012

Volltextzugriff (PDF)

Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite Antiphospholipid Syndrome

Lupus, 2012-06, Vol.21 (7), p.784-786

2012

Volltextzugriff (PDF)

Circulating beta 2 glycoprotein I-IgG anti- beta 2 glycoprotein I immunocomplexes in patients with definite Antiphospholipid Syndrome

Lupus, 2012-06, Vol.21 (7), p.784-786

2012

Volltextzugriff (PDF)

Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)

Thrombosis research, 2010-08, Vol.126 (2), p.150-153

2010

Volltextzugriff (PDF)

Antibodies to Domain I of β2 Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

Thrombosis research, 2011-12, Vol.128 (6), p.583-586

2011

Volltextzugriff (PDF)

Outcomes with oral anticoagulation resumption or discontinuation after an anticoagulation-related event in patients with atrial fibrillation

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Diabetes Care
(12)
Lupus
(8)
European Heart Journal
(7)
Thrombosis Research
(7)
Journal Of Thrombosis And Haemostasis
(5)
Scientific Reports
(4)
Autoimmunity Reviews
(3)
European Heart Journal Supplements
(3)
Nature Genetics
(3)
Plos One
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Antiphospholipid syndrome: antibodies to Domain 1 of β2‐glycoprotein 1 correctly classify patients at risk

ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study

The role of platelets in antiphospholipid syndrome

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial

Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns

Thrombocytopenia in high‐risk patients with antiphospholipid syndrome

Low platelet count at admission has an adverse impact on outcome in patients with acute coronary syndromes: from the START Antiplatelet registry

Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile

Standardized Low―Molecular-Weight Heparin Bridging Regimen in Outpatients on Oral Anticoagulants Undergoing Invasive Procedure or Surgery: An Inception Cohort Management Study

An in vitro model to mimic the thrombotic occlusion of small vessels in catastrophic antiphospholipid syndrome (CAPS)

Correct laboratory approach to APS diagnosis and monitoring

Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs)

APS - Diagnostics and challenges for the future

Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles

Antibodies to Domain I of β(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

Laboratory testing for antiphospholipid syndrome

Interpretation of laboratory data and need for reference laboratories

Antiphospholipid syndrome: critical analysis of the diagnostic path

Secondary prevention in thrombotic antiphospholipid syndrome

Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite Antiphospholipid Syndrome

Circulating beta 2 glycoprotein I-IgG anti- beta 2 glycoprotein I immunocomplexes in patients with definite Antiphospholipid Syndrome

Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)

Antibodies to Domain I of β2 Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

Outcomes with oral anticoagulation resumption or discontinuation after an anticoagulation-related event in patients with atrial fibrillation

Suchergebnisse filtern